MentionFox
Home › funding signals › Reticular
Accelerator · announced

Reticular (YC F24) — Scaling genomic AI for embryo selection

Reticular is scaling polygenic prediction for embryo selection, helping IVF couples plan their families today while building a platform to unlock cures for complex heritable diseases long-term. John competed Biology Olympiads before spending 4 years at MIT publishing ML/bio research in NeurIPS and Nature.

Reticular is a Y Combinator company in the Fall 2024 batch. Its directory entry describes it as: Scaling Genomic AI for Embryo Selection. The founder listed is John Yang (Founder/CEO) (Y Combinator directory entry, November 7, 2024).

6 more companies from YC Fall 2024 ↓

Run the free check on Reticular →

Sell to companies like Reticular? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Reticular

New accelerator entry · 2024-11-07 · the record

Fall 2024
batch
2
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchFall 2024
Announced2024-11-07
StageEarly
StatusActive
Team size2
IndustryHealthcare
Sub-industryHealthcare -> Consumer Health and Wellness
SectorsGenerative AI, Consumer Health Services, Biotech
RegionsUnited States of America, America / Canada
BasedSan Francisco, CA, USA
HiringNo
Sitehttps://reticular.com
Previously known asAdvocate

Pitching, partnering or investing alongside them? See who really runs and owns Reticular.

Free to see. No signup.

Keep reading

More on Reticular and the records around it.

Also in YC Fall 2024

Same batch, Healthcare first.

What do you want to do with Reticular?

Get the full cited report on Reticular

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Reticular: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Reticular is scaling polygenic prediction for embryo selection, helping IVF couples plan their families today while building a platform to unlock cures for complex heritable diseases long-term. John competed Biology Olympiads before spending 4 years at MIT publishing ML/bio research in NeurIPS and Nature. We believe biological models encode far more information than anyone is currently using - our goal is to unlock this potential.

Want the whole picture on Reticular?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Reticular: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Reticular covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Reticular: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Reticular. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Reticular: Accepted into Y Combinator Fall 2024
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-reticular
Last updated 2026-10-20
Primary record: Y Combinator directory entry
Reticular (YC F24) — Scaling genomic AI for embryo selection. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-reticular